Skip to main navigation Skip to search Skip to main content

Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma

  • Qian Xie
  • , Robert Bradley
  • , Liang Kang
  • , Julie Koeman
  • , Maria Libera Ascierto
  • , Andrea Worschech
  • , Valeria De Giorgi
  • , Ena Wang
  • , Lisa Kefene
  • , Yanli Su
  • , Curt Essenburg
  • , Dafna W. Kaufman
  • , Tom DeKoning
  • , Mark A. Enter
  • , Timothy J. O'Rourke
  • , Francesco M. Marincola
  • , George F. Vande Woude
  • Van Andel Research Institute
  • National Institutes of Health (NIH)
  • Spectrum Health

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)570-575
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume109
Issue number2
DOIs
StatePublished - Jan 10 2012

ASJC Scopus Subject Areas

  • General

Keywords

  • Hepatocyte growth factor-autocrine loop
  • Molecular marker
  • Oncogene addiction
  • Targeted therapy

Cite this